|
|
|
|
|
|
|
|
|
|
Compound Details | |||||
S.No. | Molceule ID (DB) | Molecule_name | VANDER SURFACE AREA 3D(+/- 5) | ||
1 | EGIN0000161 | Doxorubicin | 713.49 | ||
2 | EGIN0000530 | 3a | 717.66 | ||
3 | EGIN0000533 | 3d | 720.3 | ||
4 | EGIN0000548 | 20 | 714.97 | ||
5 | EGIN0000563 | 35 | 717.7 | ||
6 | EGIN0000649 | BMS-599626 | 720.82 | ||
7 | EGIN0001030 | 1q | 718.05 | ||
8 | EGIN0001358 | 1l | 722.35 | ||
9 | EGIN0001365 | 12b | 713.45 | ||
10 | EGIN0001409 | 15i | 719.26 | ||
11 | EGIN0001411 | 15k | 719.48 | ||
12 | EGIN0001478 | 45 | 722.45 | ||
13 | EGIN0001480 | 2 | 719.88 | ||
14 | EGIN0001593 | 14 | 721.1 | ||
15 | EGIN0001600 | 21 | 721.78 | ||
16 | EGIN0001614 | 9 | 713.16 | ||
17 | EGIN0001622 | 15e | 717.62 | ||
18 | EGIN0001842 | 7 | 716.2 | ||
19 | EGIN0001896 | 20 | 717.69 | ||
20 | EGIN0001983 | 12h | 721.49 | ||
21 | EGIN0001987 | 12l | 717.44 | ||
22 | EGIN0001991 | 12p | 713.83 | ||
23 | EGIN0001996 | 16c | 722.17 | ||
24 | EGIN0002012 | 14 | 720.92 | ||
25 | EGIN0002321 | 22 | 716.26 | ||
26 | EGIN0002349 | 7e | 720.91 | ||
27 | EGIN0002351 | 18a | 719.53 | ||
28 | EGIN0002476 | PQIP | 717.49 | ||
29 | EGIN0002995 | 1 | 713.87 | ||
30 | EGIN0003012 | 26c | 719.08 | ||
31 | EGIN0003108 | 23 | 721.65 | ||
32 | EGIN0003113 | 28 | 717.59 | ||
33 | EGIN0003160 | 4 | 713.5 | ||
34 | EGIN0003192 | 3n | 720.21 | ||
35 | EGIN0003544 | AG588 | 721.82 | ||
36 | EGIN0003548 | AG573 | 713.19 | ||
37 | EGIN0003787 | 39 | 720.76 | ||
38 | EGIN0004093 | 1j | 716.65 | ||
39 | EGIN0004100 | 18 | 720.19 | ||
40 | EGIN0004188 | 5 | 720.45 | ||
41 | EGIN0004194 | 11 | 713.9 | ||
42 | EGIN0004195 | 12 | 720.85 | ||
43 | EGIN0004265 | 13f | 720.67 | ||
44 | EGIN0004294 | 12 | 716 | ||
45 | EGIN0004359 | WZ4003 | 717.19 | ||
46 | EGIN0004516 | 3r | 717.7 | ||
47 | EGIN0004524 | 3i (reversiable) | 717.79 | ||
48 | EGIN0004539 | 34c | 722.42 | ||
49 | EGIN0004554 | 2n | 716.25 | ||
50 | EGIN0004566 | 2d | 718.97 | ||
51 | EGIN0004829 | 7 | 714.12 |